Abstract: Systems and methods for training an implant plan evaluation model is provided. A first implant plan option having a first set of parameters and a second implant plan option having a second set of parameters may be received. The first set of parameters and the second set of parameters may be inputted into a model configured to score the first implant plan option based on the first set of parameters and the second implant plan option based on the second set of parameters. The score of the first implant plan option and the score of the second implant plan option may be compared. when the score of the second implant plan option is higher than the score of the first implant plan option the model may be adjusted to score the first implant plan option higher than the second implant plan option.

Abstract: A device comprises at least one processor and memory including instructions that when executed by the at least one processor cause the at least one processor to: generate, based on at least one image of a spine within a body, a set of possible screw poses for implanting at least one screw into the spine during a surgical procedure; evaluate each possible screw pose based on at least one consideration associated with the surgical procedure; select, based on the evaluation, at least one screw pose from the set of possible screw poses; and output an indication of the selected at least one screw pose to a user interface.

Abstract: The present invention discloses a system, method, and computer program product for determining an optimal compressive pressure of an exsanguination tourniquet and an exsanguination tourniquet, system, and method of assembly. The method includes obtaining at least one parameter related to a tourniquet material, at least one parameter related to the tourniquet positioning, and identifying information comprising a description of at least one component of the tourniquet, selecting program instructions for execution by the processor, determining a compressive pressure of the tourniquet by executing selected program instructions, and determining if the compressive pressure of the tourniquet is optimized.

Abstract: The exsanguination tourniquet includes a constricting member and at least one sleeve removably coupled to the constricting member. The system includes the exsanguination tourniquet and an applicator device. The method of assembling includes obtaining a constricting member, obtaining at least one sleeve, and wrapping the at least one sleeve around the constricting member.

Abstract: The present invention discloses a system, method, and computer program product for determining an optimal compressive pressure of an exsanguination tourniquet and an exsanguination tourniquet, system, and method of assembly. The method includes obtaining at least one parameter related to a tourniquet material, at least one parameter related to the tourniquet positioning, and identifying information comprising a description of at least one component of the tourniquet, selecting program instructions for execution by the processor, determining a compressive pressure of the tourniquet by executing selected program instructions, and determining if the compressive pressure of the tourniquet is optimized.

Abstract: The exsanguination tourniquet includes a constricting member and at least one sleeve removably coupled to the constricting member. The system includes the exsanguination tourniquet and an applicator device. The method of assembling includes obtaining a constricting member, obtaining at least one sleeve, and wrapping the at least one sleeve around the constricting member.

Abstract: Pharmaceutical compositions useful for treating autoimmune diseases in a mammal comprising as an active ingredient a therapeutically effective amount of Copolymer 1, and microcrystalline cellulose are disclosed. Processes for the manufacture of such compositions are also disclosed.

Abstract: Pharmaceutical compositions useful for treating autoimmune diseases in a mammal comprising as an active ingredient a therapeutically effective amount of Copolymer 1, and microcrystalline cellulose are disclosed. Processes for the manufacture of such compositions are also disclosed.

Abstract: The present invention relates to the treatment of multiple sclerosis by ingestion or inhalation of copolymet-1 and pharmaceutical compositions useful for such treatment.